Larimar Therapeutics (LRMR) Current Assets (2013 - 2026)
Larimar Therapeutics (LRMR) posted Current Assets of $160.67 million for Q2 2026, up 10.4% from $145.56 million a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Larimar Therapeutics' Current Assets came in at $142.02 million, down 27.3% from FY2024.
- Annual Current Assets shows a five-year compound annual growth rate of 7.7% (FY2020 to FY2025).
- In prior years, Larimar Therapeutics' Current Assets was $195.3 million in FY2024 (+116.6%), $90.18 million in FY2023 (-25.3%), $120.74 million in FY2022 (+67.2%) and $72.2 million in FY2021 (-26.3%).
- Quarterly Current Assets has run from a low of $56.74 million in Q2 2022 to a high of $231.13 million in Q2 2024 over five years.
- On a year-over-year basis, Current Assets increased in three of the last seven quarters, with growth averaging 19.5%.
- The strongest year-over-year quarter for Current Assets in the past five years was Q2 2024, with growth of 117.1%; the weakest was Q2 2025, with a decline of 37.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Larimar Therapeutics | 329.31 Mn | -277.77 Mn | - | 160.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 160.67 Mn |
| Dec 31, 2025 | 142.02 Mn |
| Sep 30, 2025 | 183.22 Mn |
| Jun 30, 2025 | 145.56 Mn |
| Mar 31, 2025 | 165.49 Mn |
| Dec 31, 2024 | 195.30 Mn |
| Sep 30, 2024 | 213.26 Mn |
| Jun 30, 2024 | 231.13 Mn |
| Mar 31, 2024 | 230.95 Mn |
| Dec 31, 2023 | 90.18 Mn |
| Sep 30, 2023 | 98.48 Mn |
| Jun 30, 2023 | 106.48 Mn |
| Mar 31, 2023 | 113.46 Mn |
| Dec 31, 2022 | 120.74 Mn |
| Sep 30, 2022 | 127.13 Mn |
| Jun 30, 2022 | 56.74 Mn |
| Mar 31, 2022 | 64.88 Mn |
| Dec 31, 2021 | 72.20 Mn |
| Sep 30, 2021 | 81.25 Mn |
| Jun 30, 2021 | 74.04 Mn |
API Access
Larimar Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();